A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice

Dengue viruses (DENV) cause an estimated 390 million infections globally. With no dengue-specific therapeutic treatment currently available, vaccination is the most promising strategy for its control. A wide range of DENV vaccines are in development, with one having already been licensed, albeit wit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:NPJ Vaccines
Autores principales: Choo, Jovin J. Y., Vet, Laura J., McMillan, Christopher L. D., Harrison, Jessica J., Scott, Connor A. P., Depelsenaire, Alexandra C. I., Fernando, Germain J. P., Watterson, Daniel, Hall, Roy A., Young, Paul R., Hobson-Peters, Jody, Muller, David A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8105366/
https://ncbi.nlm.nih.gov/pubmed/33963191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-021-00328-1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares